Bulado, Irene R.
HRN: 26-65-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2025
CEFUROXIME 1.5GM (VIAL)
02/02/2025
02/09/2025
IV
1.5
Q8
For OR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes